|
|
||||||||
1 From the Department of Pediatrics, University of Cincinnati College of Medicine, Division of Hematology and Oncology, The Childrens Hospital Research Foundation, Cincinnati, Ohio; and the 2 Smith-Kettlewell Eye Research Institute, San Francisco, California.
PURPOSE. Retinal neovascularization occurring as a complication of diabetes mellitus can cause vision loss and blindness. The identification and study of novel genes involved in retinal angiogenesis may define new targets to suppress retinal neovascularization in diabetes and other ocular diseases. A novel acetyltransferase subunit, tubedown-1 (tbdn-1), has been isolated, the expression of which is regulated during blood vessel development. Tbdn-1 is not detected in most adult vascular beds but persists at high levels in the adult ocular vasculature. The purpose of this study was to gain insight into the possible role of tbdn-1 in retinal blood vessels by characterizing its expression patterns in adult homeostasis and in retinal neovascularization associated with diabetes.
METHODS. Western blot analysis and immunohistochemistry were performed to study the expression patterns of tbdn-1 during adult homeostasis in normal human retinas, in a model of choroidretina endothelial capillary outgrowth in vitro, and in retinas showing neovascularization in patients with proliferative diabetic retinopathy (PDR).
RESULTS. In adults during homeostasis, tbdn-1 was expressed highly in normal endothelium of retinal and limbic blood vessels. Tbdn-1 was also expressed in RF/6A, a rhesus macaque choroid-retinaderived endothelial cell line. In an in vitro model system using the RF/6A cell line, tbdn-1 expression was downregulated during the outgrowth of these cells into capillary-like structures on a reconstituted basement membrane matrix. Similar to this in vitro model, tbdn-1 expression is specifically suppressed in the endothelial cells of blood vessels and capillary fronds in vivo in both the neural retinal tissue and in preretinal membranes in eyes of patients with PDR.
CONCLUSIONS. High levels of expression of tbdn-1 are associated with ocular endothelial homeostasis in adults. Conversely, low levels of tbdn-1 expression are associated with endothelial capillary outgrowth in vitro and retinal neovascularization in vivo. Because the tbdn-1 acetyltransferase subunit is a member of a family of regulatory enzymes that are known to control a range of processes, including cell growth and differentiation, through posttranslational modification, the current results support a hypothesis that tbdn-1 may be involved in maintaining homeostasis and preventing retinal neovascularization.
This article has been cited by other articles:
![]() |
H. Paradis, T. Islam, S. Tucker, L. Tao, S. Koubi, and R. L. Gendron Tubedown associates with cortactin and controls permeability of retinal endothelial cells to albumin J. Cell Sci., June 15, 2008; 121(12): 1965 - 1972. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. T. Martin, R. L. Gendron, J. A. Jarzembowski, A. Perry, M. H. Collins, C. Pushpanathan, E. Miskiewicz, V. P. Castle, and H. Paradis Tubedown Expression Correlates with the Differentiation Status and Aggressiveness of Neuroblastic Tumors Clin. Cancer Res., March 1, 2007; 13(5): 1480 - 1487. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bilton, N. Mazure, E. Trottier, M. Hattab, M.-A. Dery, D. E. Richard, J. Pouyssegur, and M. C. Brahimi-Horn Arrest-defective-1 Protein, an Acetyltransferase, Does Not Alter Stability of Hypoxia-inducible Factor (HIF)-1{alpha} and Is Not Induced by Hypoxia or HIF J. Biol. Chem., September 2, 2005; 280(35): 31132 - 31140. [Abstract] [Full Text] [PDF] |
||||
![]() |
W V Good and R L Gendron Retinopathy of prematurity's turning point Br. J. Ophthalmol., February 1, 2005; 89(2): 127 - 128. [Full Text] [PDF] |
||||
![]() |
D. S. Wall, R. L. Gendron, W. V. Good, E. Miskiewicz, M. Woodland, K. Leblanc, and H. Paradis Conditional Knockdown of Tubedown-1 in Endothelial Cells Leads to Neovascular Retinopathy Invest. Ophthalmol. Vis. Sci., October 1, 2004; 45(10): 3704 - 3712. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |